Presentation is loading. Please wait.

Presentation is loading. Please wait.

P3-255: Tumor size as a prognostic factor for the survival of surgically treated stage Ia non-small cell carcinoma  Gustavo A. Lyons, Silvia Quadrelli,

Published byEverett Carr Modified over 5 years ago

Similar presentations

Presentation on theme: "P3-255: Tumor size as a prognostic factor for the survival of surgically treated stage Ia non-small cell carcinoma  Gustavo A. Lyons, Silvia Quadrelli,"— Presentation transcript:

1 P3-255: Tumor size as a prognostic factor for the survival of surgically treated stage Ia non-small cell carcinoma  Gustavo A. Lyons, Silvia Quadrelli, Domingo J. Chimondeguy, Alejandro Iotti, Carlos Silva, Karina Vera  Journal of Thoracic Oncology  Volume 2, Issue 8, Pages S787-S788 (August 2007) DOI: /01.JTO Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

2 Journal of Thoracic Oncology 2007 2, S787-S788DOI: (10. 1097/01. JTO
Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

3 Journal of Thoracic Oncology 2007 2, S787-S788DOI: (10. 1097/01. JTO
Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "P3-255: Tumor size as a prognostic factor for the survival of surgically treated stage Ia non-small cell carcinoma  Gustavo A. Lyons, Silvia Quadrelli,"

Similar presentations

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
Frances A Shepherd, MD, Rafael Rosell, MD  Journal of Thoracic Oncology 

Frances A Shepherd, MD, Rafael Rosell, MD  Journal of Thoracic Oncology 
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.

A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD 

Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD 
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
PUBLISH ONLY Journal of Thoracic Oncology

PUBLISH ONLY Journal of Thoracic Oncology
P1-021: Clinical Feature and Effectiveness of Chemotherapy in Elderly Lung Cancer Patients  Kyoungju Lee, Jinyong Jung, Sungyong Lee, Sangyeub Lee, Jehyeong.

P1-021: Clinical Feature and Effectiveness of Chemotherapy in Elderly Lung Cancer Patients  Kyoungju Lee, Jinyong Jung, Sungyong Lee, Sangyeub Lee, Jehyeong.
E13-01: Insights into thymic epithelial tumor: pathology

E13-01: Insights into thymic epithelial tumor: pathology
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
SC17.02 Lung Cancer in China: Challenges and Perspectives

SC17.02 Lung Cancer in China: Challenges and Perspectives
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy 

Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy 
Brett W. Carter, MD, Edith M. Marom, MD, Frank C. Detterbeck, MD 

Brett W. Carter, MD, Edith M. Marom, MD, Frank C. Detterbeck, MD 
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K

Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K
P2-090: Expression of cellular retinol binding protein-1 is associated with poor prognosis of stage I non-small cell lung cancer  Moo Suk Park, Yoon Soo.

P2-090: Expression of cellular retinol binding protein-1 is associated with poor prognosis of stage I non-small cell lung cancer  Moo Suk Park, Yoon Soo.
NA  Journal of Thoracic Oncology 

NA  Journal of Thoracic Oncology 
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 

The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 

Similar presentations

Ads by Google